• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化中血脂异常诱导的细胞衰老的新见解。

New insight into dyslipidemia-induced cellular senescence in atherosclerosis.

机构信息

Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China.

Institute of Aging and Age-related Disease Research, Central South University, Changsha, Hunan, 410011, PR China.

出版信息

Biol Rev Camb Philos Soc. 2022 Oct;97(5):1844-1867. doi: 10.1111/brv.12866. Epub 2022 May 15.

DOI:10.1111/brv.12866
PMID:35569818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9541442/
Abstract

Atherosclerosis, characterized by lipid-rich plaques in the arterial wall, is an age-related disorder and a leading cause of mortality worldwide. However, the specific mechanisms remain complex. Recently, emerging evidence has demonstrated that senescence of various types of cells, such as endothelial cells (ECs), vascular smooth muscle cells (VSMCs), macrophages, endothelial progenitor cells (EPCs), and adipose-derived mesenchymal stem cells (AMSCs) contributes to atherosclerosis. Cellular senescence and atherosclerosis share various causative stimuli, in which dyslipidemia has attracted much attention. Dyslipidemia, mainly referred to elevated plasma levels of atherogenic lipids or lipoproteins, or functional impairment of anti-atherogenic lipids or lipoproteins, plays a pivotal role both in cellular senescence and atherosclerosis. In this review, we summarize the current evidence for dyslipidemia-induced cellular senescence during atherosclerosis, with a focus on low-density lipoprotein (LDL) and its modifications, hydrolysate of triglyceride-rich lipoproteins (TRLs), and high-density lipoprotein (HDL), respectively. Furthermore, we describe the underlying mechanisms linking dyslipidemia-induced cellular senescence and atherosclerosis. Finally, we discuss the senescence-related therapeutic strategies for atherosclerosis, with special attention given to the anti-atherosclerotic effects of promising geroprotectors as well as anti-senescence effects of current lipid-lowering drugs.

摘要

动脉粥样硬化(atherosclerosis)以动脉壁中的富含脂质斑块为特征,是一种与年龄相关的疾病,也是全球范围内主要的致死原因。然而,其具体机制仍然复杂。最近,新出现的证据表明,各种类型的细胞衰老,如内皮细胞(endothelial cells,ECs)、血管平滑肌细胞(vascular smooth muscle cells,VSMCs)、巨噬细胞、内皮祖细胞(endothelial progenitor cells,EPCs)和脂肪来源的间充质干细胞(adipose-derived mesenchymal stem cells,AMSCs),都与动脉粥样硬化有关。细胞衰老和动脉粥样硬化具有共同的致病刺激因素,其中血脂异常备受关注。血脂异常主要指致动脉粥样硬化脂质或脂蛋白的血浆水平升高,或抗动脉粥样硬化脂质或脂蛋白的功能受损,在细胞衰老和动脉粥样硬化中都起着关键作用。在这篇综述中,我们总结了血脂异常诱导动脉粥样硬化过程中细胞衰老的现有证据,重点介绍了低密度脂蛋白(low-density lipoprotein,LDL)及其修饰物、富含甘油三酯脂蛋白(triglyceride-rich lipoproteins,TRLs)的水解产物和高密度脂蛋白(high-density lipoprotein,HDL)。此外,我们描述了将血脂异常诱导的细胞衰老与动脉粥样硬化联系起来的潜在机制。最后,我们讨论了与动脉粥样硬化相关的衰老治疗策略,特别关注有前途的抗衰老剂的抗动脉粥样硬化作用以及现有降脂药物的抗衰老作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cf2/9541442/a952cdf1fa65/BRV-97-1844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cf2/9541442/a4f9b98cb0c2/BRV-97-1844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cf2/9541442/dd53d9bcbc0d/BRV-97-1844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cf2/9541442/a952cdf1fa65/BRV-97-1844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cf2/9541442/a4f9b98cb0c2/BRV-97-1844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cf2/9541442/dd53d9bcbc0d/BRV-97-1844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cf2/9541442/a952cdf1fa65/BRV-97-1844-g002.jpg

相似文献

1
New insight into dyslipidemia-induced cellular senescence in atherosclerosis.动脉粥样硬化中血脂异常诱导的细胞衰老的新见解。
Biol Rev Camb Philos Soc. 2022 Oct;97(5):1844-1867. doi: 10.1111/brv.12866. Epub 2022 May 15.
2
Triglyceride-Rich Lipoproteins: Their Role in Atherosclerosis.富含甘油三酯的脂蛋白:在动脉粥样硬化中的作用。
Rev Invest Clin. 2022 Mar 15;74(2):061-070. doi: 10.24875/RIC.21000416.
3
Triglyceride-rich lipoproteins and cardiovascular diseases.富含甘油三酯的脂蛋白与心血管疾病。
Front Endocrinol (Lausanne). 2024 May 31;15:1409653. doi: 10.3389/fendo.2024.1409653. eCollection 2024.
4
Dyslipidemia Part 1--Review of Lipid Metabolism and Vascular Cell Physiology.血脂异常 第1部分——脂质代谢与血管细胞生理学综述
Vasc Endovascular Surg. 2016 Feb;50(2):107-18. doi: 10.1177/1538574416628654.
5
Postprandial lipoproteins and the molecular regulation of vascular homeostasis.餐后脂蛋白与血管稳态的分子调控。
Prog Lipid Res. 2013 Oct;52(4):446-64. doi: 10.1016/j.plipres.2013.06.001. Epub 2013 Jun 15.
6
Pitavastatin: novel effects on lipid parameters.匹伐他汀:对血脂参数的新作用。
Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X.
7
Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis.动脉粥样硬化中的血管平滑肌细胞死亡、自噬和衰老。
Cardiovasc Res. 2018 Mar 15;114(4):622-634. doi: 10.1093/cvr/cvy007.
8
[Dyslipidemia and atherosclerosis].[血脂异常与动脉粥样硬化]
Nihon Rinsho. 2011 Jan;69(1):138-43.
9
Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.血脂异常与心血管疾病预防:根据脂质表型调整治疗方案
Curr Cardiol Rep. 2017 Jul;19(7):61. doi: 10.1007/s11886-017-0869-3.
10
Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol.致动脉粥样硬化性血脂异常综合征的药物靶向治疗:降低低密度脂蛋白胆固醇之外心血管疾病预防的新前沿
Diabetes. 2016 Jul;65(7):1767-78. doi: 10.2337/db16-0046.

引用本文的文献

1
Association between long-term atherogenic index of plasma and carotid atherosclerosis: a prospective cohort study of a health examination population.血浆长期致动脉粥样硬化指数与颈动脉粥样硬化之间的关联:一项针对健康体检人群的前瞻性队列研究。
BMJ Open. 2025 Jul 30;15(7):e098874. doi: 10.1136/bmjopen-2025-098874.
2
Non-linear association between the dietary index for gut microbiota and the atherogenic index of plasma: insights from a cross-sectional study.肠道微生物群饮食指数与血浆致动脉粥样硬化指数之间的非线性关联:一项横断面研究的见解
Front Cardiovasc Med. 2025 Jul 4;12:1556650. doi: 10.3389/fcvm.2025.1556650. eCollection 2025.
3

本文引用的文献

1
Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies.白细胞介素-1 在肥胖相关低度炎症中的作用:从分子机制到治疗策略。
Int Immunopharmacol. 2021 Jul;96:107765. doi: 10.1016/j.intimp.2021.107765. Epub 2021 May 17.
2
Aging-dependent regulatory cells emerge in subcutaneous fat to inhibit adipogenesis.衰老相关调节细胞出现在皮下脂肪中,以抑制脂肪生成。
Dev Cell. 2021 May 17;56(10):1437-1451.e3. doi: 10.1016/j.devcel.2021.03.026. Epub 2021 Apr 19.
3
Fluorescent nanocarriers targeting VCAM-1 for early detection of senescent endothelial cells.
The therapeutic effects of natural organosulfur compounds on atherosclerosis and their potential mechanisms: a comprehensive review.
天然有机硫化合物对动脉粥样硬化的治疗作用及其潜在机制:综述
Front Cardiovasc Med. 2025 Jul 1;12:1599154. doi: 10.3389/fcvm.2025.1599154. eCollection 2025.
4
Association of lipidome with senility and the mediated effect of metabolites: A Mendelian randomization study.脂质组与衰老的关联及代谢物的介导作用:一项孟德尔随机化研究
Medicine (Baltimore). 2025 Jul 4;104(27):e43093. doi: 10.1097/MD.0000000000043093.
5
Mechanisms of endothelial senescence and vascular aging.内皮细胞衰老与血管老化的机制。
Biogerontology. 2025 Jun 25;26(4):128. doi: 10.1007/s10522-025-10279-y.
6
Contribution of multimodal ultrasound in evaluating the efficacy of lumbricus protein fast dissolving tablets against atherosclerotic plaques in ApoE mice.多模态超声在评估地龙蛋白速溶片对载脂蛋白E基因敲除小鼠动脉粥样硬化斑块疗效中的作用
Front Pharmacol. 2025 May 30;16:1551833. doi: 10.3389/fphar.2025.1551833. eCollection 2025.
7
Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects.血管衰老:机制、临床意义及治疗前景
Biogerontology. 2025 May 26;26(3):118. doi: 10.1007/s10522-025-10256-5.
8
Two-Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study.中国人群残余胆固醇与卒中风险的两年变化:一项前瞻性队列研究
J Am Heart Assoc. 2025 Jun 3;14(11):e038559. doi: 10.1161/JAHA.124.038559. Epub 2025 May 22.
9
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia: evidence from CHARLS.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与肌肉减少症之间的关联:来自中国健康与养老追踪调查(CHARLS)的证据
Front Public Health. 2025 Apr 30;13:1585986. doi: 10.3389/fpubh.2025.1585986. eCollection 2025.
10
Relationships between atherogenic index of plasma and body mass index with the risk of type 2 diabetes mellitus: insights from CHARLS.血浆致动脉粥样硬化指数与体重指数和2型糖尿病风险之间的关系:来自中国健康与养老追踪调查(CHARLS)的见解
Acta Diabetol. 2025 May 7. doi: 10.1007/s00592-025-02516-0.
靶向血管细胞黏附分子-1的荧光纳米载体用于衰老内皮细胞的早期检测。
Nanomedicine. 2021 Jun;34:102379. doi: 10.1016/j.nano.2021.102379. Epub 2021 Mar 11.
4
SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis.SIRT6 保护平滑肌细胞免于衰老并减少动脉粥样硬化。
Circ Res. 2021 Feb 19;128(4):474-491. doi: 10.1161/CIRCRESAHA.120.318353. Epub 2020 Dec 22.
5
Postprandial triglyceride-rich lipoproteins-induced premature senescence of adipose-derived mesenchymal stem cells via the SIRT1/p53/Ac-p53/p21 axis through oxidative mechanism.餐后富含甘油三酯的脂蛋白通过氧化机制通过 SIRT1/p53/Ac-p53/p21 轴诱导脂肪间充质干细胞过早衰老。
Aging (Albany NY). 2020 Dec 9;12(24):26080-26094. doi: 10.18632/aging.202298.
6
SPATA4 improves aging-induced metabolic dysfunction through promotion of preadipocyte differentiation and adipose tissue expansion.SPATA4 通过促进前脂肪细胞分化和脂肪组织扩张来改善衰老引起的代谢功能障碍。
Aging Cell. 2021 Jan;20(1):e13282. doi: 10.1111/acel.13282. Epub 2020 Dec 13.
7
Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE mice.非瑟酮通过调节载脂蛋白E基因敲除小鼠的前蛋白转化酶枯草溶菌素9型(PCSK9)和凝集素样氧化低密度脂蛋白受体1(LOX-1)来改善动脉粥样硬化。
Exp Ther Med. 2021 Jan;21(1):25. doi: 10.3892/etm.2020.9457. Epub 2020 Nov 9.
8
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease.凝集素样氧化型低密度脂蛋白受体-1(LOX-1):动脉粥样硬化性心血管疾病的关键驱动因素。
Eur Heart J. 2021 May 7;42(18):1797-1807. doi: 10.1093/eurheartj/ehaa770.
9
The secretome of senescent preadipocytes influences the phenotype and function of cells of the vascular wall.衰老前脂肪细胞的分泌蛋白组会影响血管壁细胞的表型和功能。
Biochim Biophys Acta Mol Basis Dis. 2021 Jan 1;1867(1):165983. doi: 10.1016/j.bbadis.2020.165983. Epub 2020 Sep 28.
10
, , and in Macrophage Response to Saturated Fatty Acids and Modified Low-Density Lipoprotein.巨噬细胞对饱和脂肪酸和修饰型低密度脂蛋白反应中的[具体内容缺失]、[具体内容缺失]和[具体内容缺失]
Korean Circ J. 2021 Jan;51(1):68-80. doi: 10.4070/kcj.2020.0117. Epub 2020 Aug 25.